Oligodendrocyte maturation has been defined based on expression of developmentally regulated antigens. However, transitions at early stages of the lineage have not been functionally characterized fully in situ. Combining 2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase (CNP)-promoter driven enhanced green fluorescent protein expression and whole-cell capacitance measurements permitted a reliable distinction between subcortical white matter NG2 ϩ oligodendrocyte progenitors (OPs) and O4 ϩ preoligodendrocytes (pre-OLs) in situ. We focused on K ϩ channels because their expression has been associated previously with the proliferation and differentiation potential of OPs. Using whole-cell patch clamp, we observed a downregulation of the delayed outward-rectifying current (I KDR ) between the NG2 ϩ and O4 ϩ stages but no significant changes in transient K ϩ -channel current (I KA ) amplitude. Tyrosine kinase inhibition in NG2 ϩ cells reduced I KDR amplitude with no effect on I KA , which mimicked the endogenous changes observed between OPs and pre-OLs. Tyrosine kinase inhibition also reduced the proliferative capacity of NG2 ϩ OPs in slice cultures. Conversely, acute platelet-derived growth factor receptor-␣ (PDGFR-␣) activation caused an increase of I KDR in NG2 ϩ but not in O4 ϩ cells. Consistent with this finding, PDGFR-␣ immunoreactivity was confined to NG2 ϩ cells with undetectable levels in O4 ϩ cells, suggesting that PDGFR-␣ signaling is absent in pre-OLs in situ. Importantly, the PDGF-induced increase of I KDR in NG2 ϩ cells was prevented by tyrosine kinase inhibition. Together, these data indicate that PDGFR-␣ and tyrosine kinase activity act via a common pathway that influences functional expression of K ϩ channels and proliferative capacity of OPs in situ.
Introduction
Oligodendrocyte development involves a sequence of cellular transitions from the proliferative oligodendrocyte progenitor cells (OPs) to mature oligodendrocytes. Distinct phases of oligodendrocyte maturation can be identified by expression of stagespecific antigens. In the white matter, chondroitin sulfate proteoglycan NG2, O4 antigen, and cyclic nucleotide phosphodiesterase (CNP) protein are indicative of OPs, pre-oligodendrocytes (preOLs), and mature oligodendrocytes, respectively (Rogister et al., 1999; Baumann and Pham-Dinh, 2001) .
Oligodendrocyte lineage cells display functional ion channels, and much of our knowledge about their expression and regulation has come from OP culture paradigms (Sontheimer et al., 1989; Attali et al., 1997; Knutson et al., 1997; Peretz et al., 1999; Schmidt et al., 1999; Chittajallu et al., 2002) . The expression of the delayed outward-rectifying K ϩ -channel (K DR ) is linked to cell cycle regulation and hence proliferative capacity because of the following: (1) a downregulation of K DR occurs as oligodendrocyte lineage cells mature (Sontheimer et al., 1989; Barres et al., 1990) ; (2) proliferative OPs express larger K DR currents (I KDR ) and higher levels of Kv1 subunit expression than cell cyclearrested OPs (Knutson et al., 1997; Chittajallu et al., 2002) ; (3) pharmacological block of I KDR is sufficient to cause cell cycle arrest (Gallo et al., 1996; Knutson et al., 1997; Ghiani et al., 1999; Schmidt et al., 1999; Chittajallu et al., 2002) ; and (4) overexpression of specific Kv1 subunits can induce OP proliferation in the absence of mitogens (Vautier et al., 2004) . Although the molecular identity of the K DR channel subunits linked to the proliferative capacity of OPs in vitro has been investigated (Attali et al., 1997; Schmidt et al., 1999; Chittajallu et al., 2002; Soliven et al., 2003; Vautier et al., 2004) , the actual cellular mechanisms underlying I KDR regulation in an environment closer to the in vivo scenario remain unexplored.
Previous functional studies performed in situ have only examined K ϩ -channel expression at the two extremes of oligodendrocyte development, i.e., OPs and/or differentiated oligodendro-cytes, or have not accurately identified the lineage stage of the recorded cells (Berger et al., 1991; Chittajallu et al., 2002; Gipson and Bordey, 2002; Nashmi et al., 2002; Yuan et al., 2002) . Therefore, relatively little is known about the time course of ion channel regulation with regard to intermediate lineage stages, such as those characterized by O4 expression. Acquisition of O4 by white matter OPs represents the point of commitment to the oligodendrocyte lineage, and hence examining any functional differences between NG2-and O4-expressing cells is of primary importance in understanding the physiological mechanisms underlying oligodendrogliogenesis.
A major hurdle in performing functional studies in situ is the visualization of oligodendrocyte lineage cells. Even more technically challenging is the reliable identification of their exact developmental stage. Here, we use the CNP-enhanced green fluorescent protein (EGFP) transgenic mouse (Belachew et al., 2001; Yuan et al., 2002) to target oligodendrocyte lineage cells in acutely isolated slices. We develop a strategy to distinguish between NG2 ϩ /O4 Ϫ and NG2 Ϫ /O4 ϩ cells in the subcortical white matter, thus permitting whole-cell patch-clamp recordings to measure K ϩ -channel expression at these two distinct lineage stages. We demonstrate that pharmacological block of platelet-derived growth factor (PDGF) receptor expression and tyrosine kinase activity leads to a downregulation of K DR channels and reduction in proliferation during early oligodendrocyte lineage transition.
Materials and Methods
Materials. The generation of the CNP-EGFP mouse used throughout this study has been described previously , and animal procedures complied with the National Institutes of Health and Children's Research Institute guidelines. In the present study, two separate CNP-EGFP transgenic lines were used (C1 and D1), and the data were pooled because no differences were noted between the two. All reagents were from Sigma (St. Louis, MO), unless otherwise stated. PDGF-AB was from Upstate Biotechnology (Waltham, MA). Genistein and daidzein (4Ј,7-dihydroxyisoflavone) were from EMD Biosciences (La Jolla, CA). Antibodies used in the study and working dilutions are as follows: rabbit polyclonal anti-NG2 (1:500), anti-Ki67 (1:500), and anti-cleaved caspase-3 (1:500) were from Chemicon (Temecula, CA), Nova Castra (Newcastle-Upon-Tyne, UK), and Cell Signaling Technology (Beverly, MA). Rabbit polyclonal anti-PDGF receptor-␣ (PDGFR-␣) (1:200) used in immunostaining of fixed brain sections was from Santa Cruz Biotechnology (Santa Cruz, CA) (C-20). Neutralizing anti-PDGFR-␣ (5 g/ml; catalog #AF-307-NA) used in the electrophysiological experiments to functionally antagonize the PDGFR-␣ was from R & D Systems (Minneapolis, MN). This antibody was raised in goat with Sf 21 cell-derived rhPDGFR-␣ extracellular domain as the immunogen. Mouse O4 hybridoma supernatant (1:20) was from American Type Culture Collection (Manassas, VA). Monoclonal anti-CNP (1:500) was from Sternberger Monoclonals (Lutherville, MD). Normal/preimmune control rabbit IgG was from Alpha Diagnostic International (San Antonio, TX). Cyanine 5-, rhodamine-, and Texas Red-conjugated secondary antibodies were from Jackson ImmunoResearch (West Grove, PA) and were all used at a dilution of 1:200.
Electrophysiology. Postnatal day 4 (P4) to P7 CNP-EGFP mice were anesthetized with isoflurane and decapitated, and brains were removed. Acutely isolated coronal slices (300 m) were prepared as described previously . After a 1 h recovery period, slices were transferred to a recording chamber and perfused with extracellular solution of the following composition: 124 mM NaCl, 3 mM KCl, 2.5 mM CaCl 2 , 1.3 mM MgSO 4 , 26 mM NaHCO 3 , 1.25 mM NaHPO4, 15 mM glucose, and 1 M tetrodotoxin, saturated with 95% O 2 /5% CO 2 at room temperature. For assessment of drug application on K ϩ -channel expression, we adopted a preincubation protocol to avoid possible washout of intracellular mediators of any drug effects that could arise after wholecell access. Therefore, in experiments in which drug application was required, slices were transferred to a second holding chamber containing 30 M genistein, 30 M daidzein, 10 M lavendustin A, 20 ng/ml PDGF, 5 g/ml anti-PDGFR-␣, or 5 g/ml normal/preimmune control rabbit IgG (or a combination of two drugs) for incubation times indicated in the figure legends. After the preincubation, slices were placed in the recording chamber and whole-cell recording was performed. Note that the perfusion solution also contained the same concentration of the drug(s) in which the slices were preincubated. Furthermore, in all cases, control slices preincubated in drug-free extracellular solution for the same incubation period were recorded from in an interleaved manner. EGFP ϩ cells were identified as described previously ). In the current study, EGFP ϩ cells in the subcortical white matter were targeted. Patch electrodes had resistances between 4 and 8 M⍀ when filled with intracellular solution of the following composition: 130 mM K-gluconate, 10 mM NaCl, 2 mM Mg-ATP, 0.3 mM Na-GTP, 10 mM HEPES, 0.6 mM EGTA, and 0.3% biocytin, adjusted to pH 7.2, 275 mOsm. The cells were voltage clamped at Ϫ60 mV. Before whole-cell recording, whole-cell capacitances and series resistances (to at least 85%) were compensated, and the corresponding values were read directly from the amplifier. Uncompensated series resistance values ranged from 6 to 19 M⍀, and average series resistances were not significantly different between comparison cell groups ( p Ͼ 0.05, Mann-Whitney U test). Depolarizing voltage-step protocols to isolate I KDR and A-type transient K ϩ -channel currents (I KA ) and activation profile analysis with Boltzmann curve fitting were as described previously (Knutson et al., 1997; Chittajallu et al., 2002) . In all of the experiments, an Axopatch 200B amplifier was used for voltage clamp (Molecular Devices, Union City, CA). Data were filtered at 10 and 5 kHz during capacitance compensation and subsequent data recording, respectively. In all cases, the traces were digitized at 10 kHz. All voltage measurements and steps were corrected for a junction potential offset. Off-line analysis was performed using Clampfit (Molecular Devices).
Immunocytochemistry. Visualization of single biocytin-filled, recorded EGFP ϩ cells and subsequent immunocytochemical characterization with anti-NG2, anti-O4, or anti-CNP was performed as described previously . For immunocytochemistry in tissue sections, P4 -P7 CNP-EGFP mice were anesthetized with isofluorane and intracardially perfused with fixative (4% paraformaldehyde), and the brain was removed. Frozen coronal tissue sections (30 -40 m) were prepared and immunostained as described previously (Belachew et al., 2003) . Images were acquired using either a Bio-Rad (Hercules, CA) MRC-1024 confocal laser scanning microscope as previously described or a Zeiss (Oberkochen, Germany) LSM 510. For all images, z sections and z steps ranged between 18 -28 and 2-3 m, respectively. Images were subsequently processed using Confocal Assistant (Todd Clark Brelje, University of Minnesota, Minneapolis, MN), LSM Image Examiner (Zeiss), or Adobe Photoshop/Illustrator (Adobe Systems, San Jose, CA). Cell counting was performed in the subcortical white matter from two to four 50 m sections (see Fig. 1 A) from at least three separate P4 -P7 CNP-EGFP mice. Only cells that coexpressed EGFP and the antigenic marker(s) in question were included in the counts.
CNP-EGFP organotypic slice cultures. The following methodology is based on that described previously (Yuan et al., 1998) . Coronal sections (150 -200 m) from P5-P7 CNP-EGFP mice were obtained using a Leica (Nussloch, Germany) VT-1000S vibratome in dissection media of the following composition: 0.3% glucose, 0.75% sucrose, 100 U/ml penicillin, and 100 g/ml streptomycin in HBSS. Sections were placed on Transwell collagen-coated polytetrafluoroethylene membranes (24 mm diameter, 3 m pore size; Corning, Corning, NY) and cultured in DMEM/F-12 medium (Invitrogen, Carlsbad, CA) containing the following: 100 U/ml penicillin (Biosource, Rockville, MD), 100 g/ml streptomycin (Biosource), 0.05 mg/ml human apotransferrin, 10 ng/ml biotin, 25 nM Na-selenite, 2.5 g/ml insulin, 100 M putrescine, 20 nM progesterone, and 5% FBS (HyClone, Logan, UT). Groups of two to three slices were placed on each membrane and maintained in culture for a total of 30 -32 h. After 5-7 h in culture, genistein (30 M), daidzein (30 M), tetraethylammonium (TEA) (1 mM), staurosporine (10 M), or appropriate vehicles for controls were added to the incubation medium. Drug treatments lasted for 24 h, after which the slices were fixed with 4% paraformaldehyde overnight at 4°C. The slices were then immunostained with anti-Ki67 or anti-cleaved caspase-3. Each experiment used coronal sections from two CNP-EGFP mice, and each experimental condition consisted of two to three slices. After confocal imaging (two to four microscopic fields per slice, 368 m 2 ), the numbers of white matter Ki67 ϩ /EGFP ϩ or cleaved caspase-3 ϩ /EGFP ϩ cells were calculated as a percentage of total white matter EGFP ϩ cells (total number of cells counted, 63-109 per microscopic field).
Proliferation assays of cultured oligodendrocyte progenitors. Primary OP cultures were prepared as described previously (Chew et al., 2005) . OPs were plated at a density of 3 ϫ 10 4 cells/cm 2 on poly-D-ornithine-coated 24 mm glass coverslips and cultured in DMEM-N1 biotin-containing media for 2-4 h. OPs were either not treated (i.e., N1) or treated with 10 ng/ml PDGF. In certain cultures, 5 g/ml anti-PDGFR-␣ was added to the media 1 h before the addition of PDGF. OPs were incubated for an additional 24 -30 h, fixed with 4% paraformaldehyde, and processed for 4Ј,6Ј-diamidino-2-phenylindole (DAPI) and Ki67 staining as described previously (Chew et al., 2005) . Cell proliferation was assessed by quantifying the number of Ki67 ϩ cells as a percentage of DAPI-positive cells Statistical analysis. All statistical analysis comparing appropriate control versus drug-treated conditions were performed with the MannWhitney U test, and results were deemed significantly different if p Ͻ 0.05: *p Ͻ 0.05, **p Ͻ 0.01; ns indicates not significant (i.e., p Ͼ 0.05).
Results

Prediction of NG2 and O4 expression in white matter EGFP
؉ cells by use of whole-cell capacitance measurements All electrophysiological recordings were performed in subcortical white matter EGFP ϩ cells of P4 -P7 CNP-EGFP mice ( Fig.  1 A) . Using a combined electrophysiological and post hoc immunocytochemical approach, we initially characterized the EGFP ϩ cells in this brain region with respect to their developmental stage within the oligodendrocyte lineage. We hypothesized that, as cells progressed along the lineage to maturity, the overall complexity of the cell and hence surface area of the cellular membrane would increase. A similar approach using fractal analysis of cell morphology has been used to successfully distinguish between oligodendrocyte lineage stages in vitro (Bernard et al., 2001 ). In the current study, we used whole-cell capacitance values as a direct measure of membrane surface area and hence cell size and complexity. We correlated these values with specific stages of oligodendrocyte development by post hoc immunocytochemistry and determined the expression of NG2 (OP), O4 (pre-OL/immature oligodendrocyte), and CNP-protein (mature oligodendrocyte) to define the distinct stages of oligodendrocyte development.
Our data show that 95% (19 of 20 EGFP ϩ cells tested) with whole-cell capacitance values ranging between 10 and 30 pF expressed NG2 (Fig, 1 B, C,G) . Furthermore, only 11% (1 of 9 cells tested) and 0% (0 of 5 cells tested) of cells within this range of capacitances were immunopositive for O4 and CNP protein, respectively (Fig. 1 B, G) . In contrast, ϳ92% (11 of 12 EGFP ϩ cells tested) that had whole-cell capacitances between 60 and 90 pF were found to be O4 ϩ ( Fig. 1 B , D,G) , with only 0% (0 of 13 cells tested) and 9% (1 of 11 cells tested) of cells with this higher range of capacitances expressing NG2 and CNP-protein, respectively (Fig. 1 B, (Fig. 1 B, G) . Therefore, only analyzing data from cells within these two groups of whole-cell capacitance values greatly minimizes inclusion of data from NG2 ϩ / O4 ϩ transition cells. For the remainder of the manuscript, the 10 -30 and 60 -90 pF white matter EGFP ϩ cells will be referred to as NG2 ϩ and O4 ϩ cells, respectively. Thus, for the majority of the following results presented, EGFP ϩ cells were classified as NG2 ϩ or O4 ϩ solely based on the cell capacitance criterion, without further post hoc immunocytochemical identification.
The single-cell post hoc immunocytochemical and whole-cell capacitance data ( Fig. 1 B) suggest that lineage overlap between NG2 ϩ and O4 ϩ cells is not very prevalent in the mouse at the ages studied (P4 -P7) (Fig. 1 B) . NG2 ϩ and O4 ϩ cells range between ϳ10 and 100 pF, but only cells with capacitances between 30 and 50 pF are likely to represent a transition stage (Fig. 1 B) . This finding is in contrast to previous immunocytochemical data suggesting that the vast majority of NG2 ϩ cells also display O4 immunoreactivity in the rat developing white matter at similar ages that were used in the present study (Reynolds and Hardy, Figure 1 . Correlation of EGFP ϩ whole-cell capacitance with NG2, O4, and CNP immunoreactivity in developing white matter. A, Coronal section of a single brain hemisphere from a P7 CNP-EGFP mouse illustrating the area (see dotted area) in which all EGFP ϩ cells were targeted for whole-cell voltage-clamp recordings and also for immunocytochemical cell counting. lv, Lateral ventricle; wm, white matter. B, After measurement of whole-cell capacitance of white matter EGFP ϩ cells, post hoc immunostaining for NG2, O4, or CNP-protein was performed. The graph illustrates the distribution of EGFP ϩ cells that were found to be positive or negative for these proteins as a function of whole-cell capacitance. C, Single example of a 17 pF white matter EGFP ϩ cell that was NG2 ϩ . Scale bar, 20 m. D, Single example of a 55 pF white matter EGFP ϩ cell that was O4 ϩ . Scale bar, 20 m. Note the larger cell body and complex arborization compared with the NG2 ϩ progenitor. E, Single example of a 124 pF white matter EGFP ϩ cell that was CNP protein ϩ . Note the presence of parallel fibers indicative of axonal myelination. Scale bar, 50 m. F, Capacitive transients of the NG2 ϩ (green), O4 ϩ (blue), and CNPprotein ϩ (red) cells shown in C-E before compensation (in response to a 5 mV depolarizing step from a holding potential of Ϫ60 mV). The actual whole-cell capacitance values were directly read from the amplifier after cancellation of the transients as described in Materials and Methods. G, Bar graph depicting the percentage of NG2 ϩ , O4 ϩ , and CNP-protein ϩ cells that possessed whole-cell capacitance values of either 10 -30 or 60 -90 pF. All cells were recorded from coronal slices of P4 -P7 CNP-EGFP mice.
1997). Therefore, we wanted to directly investigate the extent of NG2 and O4 overlap in white matter EGFP ϩ cells in our transgenic mouse strain. Immunocytochemical analyses on populations of white matter EGFP ϩ cells showed a relatively small 10 -20% coexpression of NG2 ϩ and O4 ϩ at the ages at which the functional analyses was performed (Fig. 2) . Our data are internally consistent, and the reason for the discrepancy with previous findings could be attributable to species differences, as suggested previously (Fanarraga et al., 1995) . Note that, at the developmental stages studied, we observed that ϳ18% of white matter EGFP ϩ cells were NG2 Ϫ /O4 Ϫ and likely represent more mature oligodendrocyte lineage cells. ϩ and O4 ϩ cells, respectively; p Ͻ 0.01; n ϭ 12) (Fig. 3 A, E,F ) . In contrast, no significant differences were noted in the amplitudes of the macroscopic I KA (measured as peak amplitude after onset of voltage step) between NG2 ϩ and O4 ϩ cells at a range of test voltage steps (average peak I KA amplitude at a test pulse of ϩ50 mV was 1115 Ϯ 104 vs 1031 Ϯ 91 pA for NG2 ϩ and O4 ϩ cells, respectively; p Ͼ 0.05; n ϭ 12) (Fig. 3 B, E,F ) .
Differential regulation of macroscopic
The relative decrease noted in I KDR amplitude between NG2 ϩ and O4 ϩ cells was not attributable to a change in the voltage dependence of activation (Fig. 3C) , because single Boltzmann fitting of normalized conductance-voltage data resulted in similar V 1/2 (Ϫ8.5 Ϯ 0.67 vs Ϫ9.8 Ϯ 0.8 mV for NG2 ϩ and O4 ϩ cells, respectively; p Ͼ 0.05; n ϭ 9) and k slope factor values (9.3 Ϯ 0.32 vs 8.6 Ϯ 0.32 for NG2
ϩ and O4 ϩ cells, respectively; p Ͼ 0.05; n ϭ 9). ϩ white matter EGFP ϩ cells (n ϭ 9). C, D, Activation conductance profiles of I KDR and I KA fitted with single Boltzmann curves for NG2 ϩ (n ϭ 12) and O4 ϩ (n ϭ 9) cells. V 1/2 and k values were not found to be significantly different ( p Ͼ 0.05, Mann-Whitney U test) between the cell groups. E, I KDR and I KA amplitude in NG2 ϩ (n ϭ 17-21) and O4 ϩ (n ϭ 15-19) cells in response to a single test pulse to ϩ50 mV. Circles without SEM represent current amplitude from each individual cell recorded, whereas circles with SEM represent the pooled data mean value. F, Single examples illustrating representative raw traces of voltage-current profiles of I KDR and I KA from an NG2 ϩ and O4 ϩ cell, respectively. All cells were recorded from coronal slices of P4 -P7 CNP-EGFP mice. Open circles, NG2 ϩ cell data; filled circles, O4 ϩ cell data. **p Ͻ 0.01, Mann-Whitney U test; ns, not significant (i.e., p Ͼ 0.05).
Tyrosine kinase inhibition in NG2
؉ cells mimics the K ؉ -channel phenotype observed in O4
؉ cells Preincubation of slices with the broad-spectrum tyrosine kinase inhibitor genistein (30 M) caused a significant decrease of the I KDR in white matter NG2 ϩ cells compared with NG2 ϩ cells from control slices (817 Ϯ 87 vs 510 Ϯ 49 pA in control NG2
ϩ cells and genistein-treated NG2 ϩ cells, respectively; p Ͻ 0.01; n ϭ 12-13) (Fig. 4 A) . Together, these data suggest the presence of a constitutive activation of tyrosine kinase activity in NG2 ϩ cells that serves to maintain K DR function. In contrast, the same concentration of genistein had no significant effect on I KA in NG2 ϩ cells (n ϭ 12-13) (Fig. 4 A) . The inactive analog of genistein, daidzein (30 M), did not significantly affect I KDR or I KA (n ϭ 8) (Fig. 4 B) . In addition, the selective inhibition of I KDR in NG2 ϩ cells by genistein was reproduced by another broad-spectrum tyrosine kinase inhibitor, lavendustin A (10 M; p Ͻ 0.01; n ϭ 5) (Fig. 4C) .
To determine whether tyrosine kinase inhibition decreases I KDR in NG2 ϩ cells to the same extent regardless of developmental stage, we replotted the data in Figure 4 , A and C, to investigate the relationship between I KDR amplitude after genistein treatment and cell capacitance. Within the NG2 ϩ cell population, cells with higher capacitance values likely correspond to more mature developmental stages that immediately precede expression of the O4 antigen. Our data demonstrate that the absolute extent of I KDR amplitude inhibition, and hence the amplitude of the residual I KDR after tyrosine kinase inhibition, did not change throughout the whole-cell capacitance range examined, i.e., at various stages of NG2 ϩ cell maturation (Fig. 4 D) . Finally, the same concentration of genistein that inhibited I KDR in NG2 ϩ cells (Fig. 4 A, C) did not significantly alter I KDR or I KA in O4 ϩ cells (n ϭ 8; p Ͼ 0.05) (Fig. 4 E) .
White matter O4
؉ cells are postmitotic We next compared the proliferative capacity of NG2 ϩ and O4 ϩ cells by examining the expression of the cell cycle-related nuclear antigen Ki67 (Scholzen and Gerdes, 2000) using immunocytochemical analysis ( Fig. 5A-E) . Ki67 immunoreactivity yields a more accurate estimate of the growth fraction of a given population of cells because this protein is expressed in all phases of the cell cycle (Scholzen and Gerdes, 2000) . This is in contrast to the other widely used markers of proliferation, bromodeoxyuridine and proliferating cell nuclear antigen, which label cells only in S-phase of the cell cycle (Bacchi and Gown, 1993) . We have previously used Ki67 expression to estimate NG2 ϩ cell proliferation in the postnatal and adult subventricular zone , but, to our knowledge, this is the first description of the assessment of white matter NG2 ϩ and O4 ϩ cell proliferation using this marker. Our present data demonstrate that 43 Ϯ 9% (total cells counted, 257) and 2 Ϯ 1% (total cells counted, 105) of total NG2 ϩ and O4 ϩ cells, respectively, expressed Ki67 and hence were proliferative (Fig. 5F ).
Together, these data clearly demonstrate that a reduction in I KDR observed as NG2 ϩ cells differentiate to O4 ϩ cells is accompanied by a loss of proliferative capacity.
Tyrosine kinase inhibition decreases the proliferative fraction of white matter EGFP
؉ cells We then investigated whether tyrosine kinase inhibition could decrease the proliferation of white matter OPs. Because (1) EGFP ϩ cells in the white matter belong to the oligodendrocyte lineage , (2) O4 ϩ cells are essentially postmitotic (Fig. 5) , and (3) it is unlikely that oligodendrocytes more mature than O4 ϩ cells are proliferative, we proposed that all of the Ki67 ϩ /EGFP ϩ cells must be NG2 ϩ OPs. We therefore quantified the extent of Ki67 immunoreactivity in white matter EGFP ϩ cells as a percentage of total white matter EGFP ϩ cells in organotypic slice cultures. We treated the slices with genistein to assess whether the reduction in I KDR amplitude noted previously was accompanied by a decrease in proliferation of OPs. In control slices, 20 Ϯ 3% (n ϭ 4; total cells counted, 656) of white matter EGFP ϩ cells were proliferative, as indicated by Ki67 expression Circles without SEM represent current amplitude from each individual cell recorded, whereas circles with SEM represent the pooled data mean value. All cells were recorded from coronal slices of P4 -P7 CNP-EGFP mice. Note that recordings from control and drug-treated slices were performed in an interleaved manner. **p Ͻ 0.01, Mann-Whitney U test; ns, not significant (i.e., p Ͼ 0.05). (Fig. 6 A, B,D) . Proliferation was significantly decreased after inhibition of tyrosine kinase by genistein (30 M) to 6 Ϯ 2% (n ϭ 3; p Ͻ 0.01; total cells counted, 431) (Fig. 6C,D) . In contrast, the inactive analog daidzein did not significantly alter the proliferative fraction of white matter EGFP ϩ cells when compared with control (14 Ϯ 8%; n ϭ 4; total cells counted, 553) (Fig. 6 D) . As expected from previous studies (Yuan et al., 1998; Ghiani et al., 1999) , direct block of K ϩ channel by 1 mM TEA significantly decreased proliferation in white matter EGFP ϩ cells to 2 Ϯ 1% (n ϭ 3; p Ͻ 0.01; total cells counted, 389) (Fig. 6D) . Finally, in drug-treated slices, cell viability was not significantly different from that seen in control slices, as assessed by cleaved caspase-3 expression (n ϭ 2-4; percentage of cleaved caspase-3 ϩ /EGFP ϩ cells were 3.3 Ϯ 1.2, 4.5 Ϯ 2.8, 5.5 Ϯ 3.1, 6.3 Ϯ 2.7, and 37.3 Ϯ 9.9% under control, genistein-, daidzein-, TEA-, and staurosporine-treated conditions, respectively; total cells counted, 189 -412) (supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). These data clearly indicate that, under our experimental conditions, inhibition of tyrosine kinase is sufficient to decrease the proliferation of white matter OPs via a mechanism that is not associated with apoptosis.
Acute PDGF receptor activation selectively increases I KDR in NG2
؉ cells via a tyrosine kinase pathway Incubation of the slices with PDGF (20 ng/ml) caused a marked increase of the I KDR amplitude in NG2 ϩ cells (925 Ϯ 74 vs 1496 Ϯ 120 pA in control NG2 ϩ cells and PDGF-treated NG2 ϩ cells, respectively; p Ͻ 0.01; n ϭ 9 -10) (Fig. 7A) . Although a small increase in the mean I KA amplitude was also noted in NG2 ϩ cells treated with PDGF, this was not statistically significant (1103 Ϯ 129 vs 1353 Ϯ 181 pA in control NG2 ϩ cells and PDGF-treated NG2 ϩ cells, respectively; p Ͼ 0.05; n ϭ 9 -10) (Fig. 7A) ϩ cells and PDGF-treated O4 ϩ cells, respectively; p Ͼ 0.05; n ϭ 10) (Fig. 7B) .
We then directly compared I KDR amplitude in NG2 ϩ cells from control slices and NG2 ϩ cells in slices that had been preincubated with the PDGFR-␣ antibody. Pooled data demonstrated that this had a small but significant decrease in I KDR (982 Ϯ 86 vs 761 Ϯ 57 pA in control NG2 ϩ cells vs PDGFR-␣ treated NG2 ϩ cells, respectively; 0.01 Ͻ p Ͻ 0.05; n ϭ 10) (Fig. 7C) . Preincubation of slices with 5 g/ml normal/preimmune control rabbit IgG did not significantly alter I KDR in NG2 ϩ cells (902 Ϯ 26 vs 861 Ϯ 40 pA in control NG2 ϩ cells vs control rabbit IgG-treated NG2 ϩ cells, respectively; p Ͼ 0.05; n ϭ 5; data not shown). These data suggest the presence of a small but measurable tonic activation of PDGFR-␣ under the conditions of our experiments and that block of this tonic activation can in fact cause a similar modulation of I KDR as tyrosine kinase inhibition. To determine that the PDGF-mediated increase of I KDR amplitude in NG2 ϩ cells occurred via the activation of PDGFR-␣, we tested whether this effect was still apparent after treatment of the slices with PDGFR-␣ antibody (R & D Systems). We confirmed that this antibody prevented the well known mitogenic effect (as assessed by Ki67 immunoreactivity) of PDGF on primary OP cultures (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material) and hence is a functional antagonist of PDGFR-␣. In slices, the PDGF-mediated increase of I KDR amplitude in NG2 ϩ cells was prevented by preincubation with this antibody (777 Ϯ 97 vs 854 Ϯ 58 pA in PDGFR-␣ antibodytreated NG2 ϩ cells vs PDGFR-␣ antibody plus PDGF-treated NG2 ϩ cells, respectively; p Ͼ 0.05; n ϭ 10 -11) (Fig. 7D) , illustrating that the positive modulation of I KDR by PDGF indeed occurs via activation of the PDGFR-␣. Note that, in these experiments, NG2
ϩ cells treated with anti-PDGFR-␣ alone were used as a control.
Finally, preincubation of NG2 ϩ cells with the tyrosine kinase inhibitor genistein prevented any subsequent PDGF-mediated increase in I KDR amplitude (454 Ϯ 64 vs 432 Ϯ 73 pA in genisteintreated NG2 ϩ cells vs genistein plus PDGF-treated NG2 ϩ cells, respectively; p Ͼ 0.05; n ϭ 7) (Fig. 7E) . The occlusion of the PDGF-induced increase of I KDR in NG2 ϩ cells by genistein strongly suggests that the effects of PDGF receptor activation on the function of this channel are mediated via a tyrosine kinase pathway. Because PDGF only modified I KDR amplitude in NG2 ϩ but not in O4 ϩ cells, we examined, using protein immunocytochemistry, whether O4 ϩ cells expressed PDGFR-␣. Our data clearly show the presence of numerous white matter EGFP ϩ cells that displayed a membrane distribution of PDGFR-␣ protein immunoreactivity (Fig. 8, arrowheads) . Furthermore, in general, these cells were smaller in size and/or expressed lower intensities of EGFP fluorescence. From previous analyses, it can be concluded that these cells represent white matter NG2 ϩ progenitors (Chittajallu et al., 2004; this study). In contrast, only in extremely rare cases was detectable PDGFR-␣ protein noted on O4 ϩ cells in the developing white matter (3 Ϯ 1% of O4 ϩ cells displayed PDGFR-␣ immunoreactivity; total cells counted, 146) (Fig. 8 ).
Discussion
Our current data illustrate that successful targeting of NG2 ϩ / O4 Ϫ or NG2 Ϫ /O4 ϩ cells can be achieved by using CNPpromoter-driven EGFP fluorescence and whole-cell capacitance measurements. This is the first description of an experimental paradigm that greatly aids physiological characterization of specific developmental stages of oligodendrocyte cells in acutely isolated slices.
Using this approach, we investigated the functional expression of I KDR in white matter NG2 ϩ and O4 ϩ cells in situ. Our data demonstrate a downregulation in I KDR as NG2
ϩ cells progress to an O4 ϩ phenotype. A proportion of white matter NG2 ϩ cells in situ were proliferative, whereas virtually all O4 ϩ cells were postmitotic. These data agree with previous in vitro studies demonstrating a correlation between expression of this channel and proliferative capacity (Gallo et al., 1996; Knutson et al., 1997; Chittajallu et al., 2002; Soliven et al., 2003) . However, the fact that white matter O4 ϩ cells identified in this study are nonproliferative but display a significant and measurable I KDR raises an important issue. This data suggests that complete inhibition of I KDR is not a prerequisite for cell cycle exit and therefore not all K DR channels are linked to cell cycle regulation. OPs express a variety Figure 7. PDGF receptor activation selectively increases I KDR in NG2 ϩ cells via a tyrosine kinase-dependent pathway. I KDR and I KA amplitudes were determined at a test pulse of ϩ50 mV as described in Materials and Methods. A, Individual and pooled I KDR and I KA amplitudes from white matter NG2 ϩ cells in control slices (open circles; n ϭ 10) versus slices that had been incubated with 20 ng/ml PDGF for 60 -90 min (filled circles; n ϭ 9). B, Individual and pooled I KDR and I KA amplitudes from white matter O4 ϩ cells in control slices (open circles; n ϭ 10) versus slices that had been incubated with 20 ng/ml PDGF for 60 -90 min (filled circles; n ϭ 9). C, Individual and pooled I KDR amplitudes from white matter NG2 ϩ cells in control slices (open circles; n ϭ 10) versus slices that had been incubated with 5 g/ml anti-PDGF for 60 -90 min (filled circles; n ϭ 10). D, Individual and pooled I KDR amplitudes from white matter NG2 ϩ cells in slices that had been incubated with 20 ng/ml PDGF for 60 -90 min (open circles; n ϭ 11) versus slices that had been incubated with 20 ng/ml PDGF for 60 -90 min in the presence of 0.5 g/ml anti-PDGF (filled circles; n ϭ 10). E, Individual and pooled I KDR amplitudes from white matter NG2 ϩ cells in slices that had been incubated with 30 m genistein for 60 -90 min (open circles; n ϭ 7) versus slices that had been incubated with 30 m genistein in the presence of 20 ng/ml PDGF for 60 -90 min (filled circles; n ϭ 7). All cells were recorded from coronal slices of P4 -P7 CNP-EGFP mice. Note that recordings from control and drug-treated slices were performed in an interleaved manner. *p Ͻ 0.05, **p Ͻ 0.01, Mann-Whitney U test; ns, not significant (i.e., p Ͼ 0.05).
of Kv1 subunit transcripts and proteins (Attali et al., 1997; Schmidt et al., 1999; Chittajallu et al., 2002) . We have shown previously that (1) Kv1.3 and Kv1.5 but not Kv1.4 or Kv1.6 subunit proteins are upregulated by PDGF in OPs in vitro, and (2) selective pharmacological inhibition of Kv1.3 alone elicits cell cycle arrest in proliferating OPs in vitro . It has also been demonstrated that levels of Kv1.5 mRNA are upregulated in cultured OPs after PDGF treatment (Soliven et al., 2003) . It is therefore possible that only certain Kv1 subunits (e.g., Kv1.3 and/or Kv1.5) are downregulated during NG2
ϩ to O4 ϩ cell lineage progression, which would explain the redundancy of certain K DR channels with respect to cell proliferation. In this study, we demonstrate that both white matter NG2 ϩ and O4 ϩ cells express I KA . However, there is no evidence for whether K A plays a role in OP proliferation. In contrast to I KDR , I KA amplitude does not significantly change during NG2 to O4 lineage progression. Although we cannot rule out possible changes in gating or kinetic properties of K A channels (Peretz et al., 1999) in OPs and pre-OLs, these data suggest that regulation of I KA amplitude plays a minor role, if any, in cell cycle regulation and early lineage progression. Interestingly, Kv1.4 homomeric and heteromeric (with other Kv subunits) channels display rapidly inactivating kinetics reminiscent of K A channels (Dolly and Parcej, 1996; Kondoh et al., 1997) , and expression of Kv1.4 mRNA and protein has been demonstrated in OPs (Attali et al., 1997; Schmidt et al., 1999; Chittajallu et al., 2002) . Therefore, Kv1.4 is a candidate subunit underlying I KA in these cells. Kv1.4 protein levels are not altered between quiescent and proliferating cultured OPs . Thus, our present in situ data strengthen the hypothesis that modulation of K A channels is not involved in the loss of proliferation during OP to pre-OL lineage progression.
Tyrosine kinase-mediated effects on K ϩ -channels are a cellular mechanism that regulates their function. However, the majority of studies in the CNS have mainly focused on neuronal populations because of the role these channels play in action potential kinetics and firing patterns (Jonas and Kaczmarek, 1996) . More recently, it has been shown that I KDR in Schwann cells (Sobko et al., 1998; Peretz et al., 1999) , astrocytes (MacFarlane and Sontheimer, 2000) , microglia (Cayabyab et al., 2000) , and oligodendrocyte progenitors (Soliven et al., 2003) in vitro can be modulated by tyrosine kinase activity, suggesting that similar mechanisms also exist in glial cells. However, it is unknown how this relates to lineage progression of white matter oligodendrocytes. In the current study, tyrosine kinase inhibition in white matter NG2 ϩ cells in situ downregulates I KDR amplitude. This demonstrates the presence of a constitutive tyrosine kinase activity that maintains high I KDR expression. Furthermore, the extent of I KDR inhibition after tyrosine kinase inhibition is similar regardless of the relative maturity of NG2 ϩ cells, as assessed by cell capacitance measurement, with a residual I KDR amplitude (ϳ500 pA) closely matching that observed in O4 ϩ cells. In contrast, I KA in NG2 ϩ cells is not affected by tyrosine kinase inhibition under the same experimental conditions that decrease I KDR . Therefore, block of tyrosine kinase activity in NG2
ϩ cells results in a functional K ϩ -channel phenotype that is reminiscent of O4 ϩ cells and hence mimics the endogenous regulation of K ϩ channels. Together, these data indicate that tyrosine kinase inhibition is a plausible mechanism that underlies the appropriate K ϩ -channel regulation as OPs develop into pre-OLs. Although pharmacological block of tyrosine kinase activity modulates K DR function, our data do not directly evaluate whether this effect is mediated via changes in phosphorylation state of tyrosine residues within these channel subunit proteins. It is clear that phosphorylation/dephosphorylation of tyrosine residues can significantly influence K ϩ -channel activity in a variety of cell types (Breitwieser, 1996; Jonas and Kaczmarek, 1996; Davis et al., 2001) . In fact, tyrosine kinase inhibition significantly decreases phosphorylation of Kv1.5 subunit in cultured astrocytes (MacFarlane and Sontheimer, 2000) and Kv1.5/Kv2.1 subunits in Schwann cells in vitro (Sobko et al., 1998) . This dephosphorylation is accompanied by a reduction in I KDR amplitude (Sobko et al., 1998; MacFarlane and Sontheimer, 2000) . Thus, it is possible that the effects of tyrosine kinase inhibition on I KDR amplitude in white matter OPs are also mediated by dephosphorylation. However, we cannot rule out the possibility that tyrosine kinase inhibition alters OP K DR function via changes in phosphorylation state of intermediate modulatory proteins.
PDGF is a well known mitogen for oligodendrocyte progenitors (Calver et al., 1998; Fruttiger et al., 1999; McKinnon et al., 2005) , and activation of PDGF receptors is linked to an increase in tyrosine kinase activity within the cell (Dolly and Parcej, 1996; DeMali Tallquist and Kazlauskas, 2004) . Interestingly, PDGF treatment caused an increase of I KDR expression in cultured OPs Soliven et al., 2003) , which occurs in part via tyrosine kinase activation (Soliven et al., 2003) . Our present data are in agreement with this latter study and demonstrate that PDGFR-␣ activation causes, on average, an increase in I KDR amplitude in white matter NG2 ϩ cells that can be occluded by previous tyrosine kinase inhibition, indicative of a common cellular pathway. However, this PDGFR-␣-mediated effect is no longer observable at the O4 ϩ stage, although these cells express I KDR , and this is attributed to a lack of detectable PDGFR-␣ protein expression as OPs become pre-OLs. The absence of PDGFR-␣ on the majority of O4 ϩ cells is in agreement with a previous study (Nishiyama et al., 1996) , and the present functional data demonstrating the inability of PDGFR-␣ activation to modulate K DR channels in O4 ϩ in situ are in favor of this class of cells being unresponsive to PDGF (Fok-Seang and Miller, 1994; Mason and Goldman, 2002) . Because, PDGFR-␣ and tyrosine kinase activity work together to maintain I KDR , we suggest that a decrease of PDGFR-␣ signaling, such as that which occurs because of PDGFR-␣ downregulation between the NG2 and O4 lineage stages, would lead to an attenuation of I KDR amplitude.
The fact that (1) only a very small fraction of O4 ϩ cells express detectable PDGFR-␣, (2) virtually all O4 ϩ cells are postmitotic, and (3) 20% of white matter O4 ϩ cells express NG2 allow us to draw some conclusions concerning the transitional NG2 ϩ /O4 ϩ cells. Together, our immunocytochemical analysis suggests that the majority of NG2 ϩ /O4 ϩ cells are also postmitotic and do not express PDGFR-␣ receptor protein. The latter is in agreement with previous studies demonstrating a loss of colocalization of NG2 and PDGFR-␣ as white matter development proceeds and the presence of OPs in vitro that possess NG2 immunoreactivity after the loss of detectable PDGFR-␣ protein (Nishiyama et al., 1996a,b) . Thus, inhibition of tyrosine kinase activity mediated by PDGFR-␣ activation is already apparent in the transitional NG2 ϩ /O4 ϩ cells. Interestingly, we do note a percentage of NG2 ϩ cells that do not express Ki67 and display I KDR amplitudes that are in a similar range to those seen in postmitotic O4 ϩ cells. Furthermore, tyrosine kinase inhibition can induce a reduction in NG2 ϩ cell proliferation. We therefore propose that reduction in PDGFR-␣-mediated tyrosine kinase activity is initiated during the late OP stage and is complete by the time cells reach NG2 Ϫ / O4 ϩ stage, because PDGFR-␣ activation and tyrosine kinase inhibition no longer modulates the residual K DR channels present at this developmental stage.
To summarize, we propose that downregulation of PDGFR-␣ receptor expression that occurs as NG2 ϩ cells attain O4 immunoreactivity results in a subsequent inhibition of tyrosine kinase activity that is normally constitutively maintained by activation of these receptors. This, in turn, inhibits I KDR function, which ultimately leads to a reduction and cessation of proliferative capacity during NG2
ϩ to O4 ϩ cell lineage progression. Future studies involving genetic manipulation resulting in gain or loss of function would serve to strengthen the hypothesis that a cellular pathway linking PDGR-␣ expression, tyrosine kinase activity, and K ϩ -channel function constitutes an important mechanism involved in oligodendrocyte development in situ.
